Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling

Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared wit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Global health science and practice 2017-12, Vol.5 (4), p.534-539
Hauptverfasser:	Ali, Moazzam, Bahamondes, Luis, Bent Landoulsi, Sihem
Format:	Artikel
Sprache:	eng
Schlagworte:	Contraceptive Agents, Female - administration & dosage Contraceptive Agents, Female - pharmacology Desogestrel - administration & dosage Desogestrel - pharmacology Drug Implants Female Humans Intrauterine Devices, Medicated Levonorgestrel - administration & dosage Levonorgestrel - pharmacology Product Labeling Randomized Controlled Trials as Topic Time Factors United States United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label). Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).
ISSN:	2169-575X 2169-575X
DOI:	10.9745/GHSP-D-17-00296